Rosalind Walmsley

Aug 20, 2023 | mja.com.au | Rosalind Walmsley |Priya Sumithran

Med J Aust 2023; 219 (4): . || doi: 10.5694/mja2.52031 Published online: 21 August 2023 In reply: We thank Inglis and colleagues1 for their interest in our review article2 and for highlighting the important issue of a possible signal for increased thyroid cancer risk with glucagon‐like peptide 1 (GLP‐1) receptor agonists raised in the study by Bezin and colleagues.3 The full article is accessible to AMA members and paid subscribers.

Jul 5, 2023 | pubmed.ncbi.nlm.nih.gov | Rosalind Walmsley |Priya Sumithran

Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software

Mar 19, 2023 | mja.com.au | Rosalind Walmsley |Priya Sumithran

Med J Aust || doi: 10.5694/mja2.51871 Published online: 20 March 2023 The prevalence of obesity among adults has nearly tripled worldwide since 1975 to more than 650 million in 2016,1 including 31% of adults in Australia.2 Obesity is the second leading contributor to Australia's burden of disease due to its complications, which include cardiovascular disease, type 2 diabetes, chronic kidney disease, fatty liver, obstructive sleep apnoea, and several cancers.2 Many of these complications can...